Peter
Levitch is a world-renowned expert in FDA regulations. Mr. Levitch
has held senior positions managing the regulatory and clinical
programs at Ortho Diagnostic Systems (a subsidiary of Johnson
& Johnson) and has been an advisor to more than 200 leading
biotechnology and biological firms, including: Amgen, Genentech,
Immunex, DuPont, Baxter, J&J. Mr. Levitch's experience and
familiarity with FDA related issues is a key asset to The Sage
Group enabling him to accomplish capital conserving yet commercially
efficient regulatory strategies and tactical programs. Mr. Levitch,
in his years of activity in the health care field, especially
in qualifying biotechnology derived products, will provide for
The Sage Group what he has so successfully provided for other
companies. The sales of the products so successfully assisted
by Mr. Levitch have annual sales in the billions of dollars.